You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

UVA1

Showing 1 - 25 of 1,099
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Detroit (Light Source B: Visible Light solar simulator (VL + UVA1), Light Source A: Visible Light solar

Recruiting
  • Healthy
  • Light Source B: Visible Light solar simulator (VL + UVA1)
  • Light Source A: Visible Light solar simulator closer match to sunlight (VL +UVA1)
  • Detroit, Michigan
    Henry Ford Medical Center
Jul 25, 2023

Cutaneous Lupus Erythematosus Trial in Dallas (UVA1 radiation treatment)

Completed
  • Cutaneous Lupus Erythematosus
  • UVA1 radiation treatment
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Nov 30, 2022

Scleroderma Trial in Murray (UVA-1 Phototherapy)

Recruiting
  • Scleroderma
  • UVA-1 Phototherapy
  • Murray, Utah
    University of Utah MidValley Dermatology
May 20, 2022

Scleroderma, Systemic, Morphea, Graft Vs Host Disease Trial in Murray (UVA-1 Phototherapy)

Enrolling by invitation
  • Scleroderma, Systemic
  • +2 more
  • UVA-1 Phototherapy
  • Murray, Utah
    University of Utah Dermatology
Nov 1, 2022

Generalized Vitiligo Trial in Detroit (Visible Light-Ultraviolet A Light or Narrowband-Ultraviolet B phototherapy)

Terminated
  • Generalized Vitiligo
  • Visible Light-Ultraviolet A Light or Narrowband-Ultraviolet B phototherapy
  • Detroit, Michigan
    Department of Dermatology, Henry Ford Medical Center, 3031 West
Feb 9, 2022

Early Disease Onset Trial (Puva (psoralin and uva ))

Not yet recruiting
  • Early Disease Onset
  • Puva (psoralin and uva )
  • (no location specified)
Sep 27, 2023

oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt

Not yet recruiting
  • HIV-1-infection
  • Therapeutic drug monitoring in plasma of mother and child and in breastmilk
  • (no location specified)
Nov 29, 2022

Tests for Visceral Leishmaniasis Diagnosis in Eastern Africa

Completed
  • Leishmaniasis, Visceral
  • Leishmania Ab Rapid Test (CTK, Biotech)
  • Gondar, Ethiopia
  • +1 more
Jun 1, 2022

Hyperopia, Hyperopic Astigmatism Trial in United States (drug, device, procedure)

Terminated
Has Results
  • Hyperopia
  • Hyperopic Astigmatism
  • riboflavin ophthalmic solution, 0% dextran
  • +3 more
  • San Diego, California
  • +4 more
Apr 22, 2021

Atopic Eczema Trial in Dundee (combined ultraviolet phototherapy (NB-UVB + UVA1) vs. NB-UVB monotherapy)

Completed
  • Atopic Eczema
  • combined ultraviolet phototherapy (NB-UVB + UVA1) vs. NB-UVB monotherapy
  • Dundee, United Kingdom
    Ninewells Hospital
Nov 5, 2020

Prediabetic State Trial in Sherbrooke (High-intensity interval training)

Recruiting
  • Prediabetic State
  • High-intensity interval training
  • Sherbrooke, Quebec, Canada
    Centre de recherche du CHUS
Nov 17, 2021

Sunburn, Sun Damaged Skin, Overexposure to Sun Rays Trial in Chile, Peru, United States (otc sunscreens, sun protection fabrics,

Enrolling by invitation
  • Sunburn
  • +2 more
  • otc sunscreens
  • +2 more
  • San Diego, California
  • +4 more
Oct 24, 2022

Lymphoma, Childhood Lymphoma, Solid Tumor Trial in Charlottesville (Genistein, Placebo)

Terminated
  • Lymphoma
  • +15 more
  • Charlottesville, Virginia
    University of Virginia
Feb 8, 2022

Keratoconus, Ectasia Trial in New York (UVA Light with irradiance exposure of 9 mW/cm2, Riboflavin 0.1% ophthalmic solution)

Recruiting
  • Keratoconus
  • Ectasia
  • UVA Light with irradiance exposure of 9 mW/cm2
  • Riboflavin 0.1% ophthalmic solution
  • New York, New York
    Edward Harkness Eye Institute-Columbia University Medical Center
Aug 18, 2021

Delirium Trial in Utrecht (Spot monitoring device, excl. Sham)

Completed
  • Delirium
  • Spot monitoring device, excl. Sham
  • Utrecht, Netherlands
    UMC Utrecht
Jul 9, 2021

Bone Health and Vitamin D Status

Active, not recruiting
  • Osteopenia
  • +2 more
    • Pathum Wan, Bangkok, Thailand
      The Thai Red Cross AIDS Research Centre
    Oct 5, 2021

    Cardiac Arrest, Anoxic Encephalopathy, Status Epilepticus Trial in Belgium, Netherlands (Anti-epileptic drugs, No anti-epileptic

    Completed
    • Cardiac Arrest
    • +2 more
    • Anti-epileptic drugs
    • No anti-epileptic drugs
    • Brussels, Lenniksebaan 808, Belgium
    • +10 more
    Feb 3, 2022

    Scleroderma, Localized, Morphea, Scleroderma, Circumscribed Trial in Dallas (UVA-1 Phototherapy, Placebo)

    Completed
    • Scleroderma, Localized
    • +2 more
    • UVA-1 Phototherapy
    • Placebo
    • Dallas, Texas
      UT Southwestern Medical Center - Department of Dermatology
    Sep 24, 2019

    Abdominal Aortic Aneurysm, Surgery, Arterial Disease Trial in Netherlands (ACT guided heparinization, 5 000 IU of heparin)

    Recruiting
    • Abdominal Aortic Aneurysm
    • +2 more
    • ACT guided heparinization
    • 5 000 IU of heparin
    • Hamburg, Germany
    • +21 more
    Dec 5, 2022

    Hookworm Infection, Hookworm Disease Trial in Lambaréné (Na-GST-1, CPG 10104)

    Completed
    • Hookworm Infection
    • Hookworm Disease
    • Na-GST-1
    • CPG 10104
    • Lambaréné, Gabon
      Centre de Récherches Médicales de Lambaréné
    Jan 12, 2021

    Advanced Solid Tumors Trial in United States (ARRY-382, Pembrolizumab)

    Terminated
    Has Results
    • Advanced Solid Tumors
    • Los Angeles, California
    • +29 more
    May 21, 2022

    Endometrial Tumors, Uterine Tumors, Endometrium Cancer Trial in Netherlands (PARP inhibitor and Anti-PD-L1)

    Active, not recruiting
    • Endometrial Neoplasms
    • +2 more
    • PARP inhibitor and Anti-PD-L1
    • Amsterdam, Netherlands
    • +7 more
    Mar 30, 2021

    Metastatic Cancer, Solid Tumors, Advanced Cancer Trial in United States (ASP9801, Pembrolizumab)

    Recruiting
    • Metastatic Cancer
    • +2 more
    • ASP9801
    • Pembrolizumab
    • Birmingham, Alabama
    • +26 more
    Jan 6, 2023

    Myocardial Infarction Trial in Amsterdam, Warsaw (Ticagrelor, Clopidogrel)

    Completed
    Has Results
    • Myocardial Infarction
    • Amsterdam, Netherlands
    • +1 more
    Nov 28, 2020

    Plexiform Neurofibroma, Neurofibromatosis Type 1 (NF1) Trial in United States (Mirdametinib (PD-0325901) oral capsule or

    Active, not recruiting
    • Plexiform Neurofibroma
    • Neurofibromatosis Type 1 (NF1)
    • Mirdametinib (PD-0325901) oral capsule or dispersible tablet
    • Birmingham, Alabama
    • +49 more
    Nov 17, 2022